ANNX — Annexin Pharmaceuticals AB (publ) Share News
0.000.00%
- SEK55.46m
- SEK50.19m
Brief: Annexin Pharmaceuticals Q4 Net Loss Narrows To SEK 7.3 Mln
Brief: Annexin Pharmaceuticals Names Henrik Palm New CFO
Brief: Annexin Pharmaceuticals Q3 Net Loss Widens To SEK 4.8 Million
Brief: Annexin Pharmaceuticals Q2 Operating Loss Narrows To SEK 7.7 Million
Brief: Annexin Pharmaceuticals Gets Sek 52 Million In Issue Payment
Brief: Annexin Pharmaceuticals Q1 Net Loss Widens To SEK 9.0 Million
Brief: Annexin Pharmaceuticals CFO To Leave Company
Brief: Annexin Pharmaceuticals Q4 Net Loss Widens To SEK 9.6 Mln
Brief: Annexin Pharmaceuticals Q3 net loss at SEK 3.8 mln
Brief: Annexin Pharmaceuticals appoints Jamal El-Mosleh new CEO
Brief: Annexin Pharmaceuticals Q2 net loss at SEK 10.1 million
Brief: Annexin Pharmaceuticals patent approved in the United States